Vicem Packaging Bim Son JSC (HNX:BPC)
Vietnam · Delayed Price · Currency is VND 11,500
+900 (8.49%)
At close: Aug 4, 2025
CTI BioPharma Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 269,350 | 268,891 | 227,620 | 263,638 | 264,008 | 249,326 | Upgrade | |
Revenue Growth (YoY) | 10.20% | 18.13% | -13.66% | -0.14% | 5.89% | -21.08% | Upgrade |
Cost of Revenue | 244,145 | 244,370 | 204,873 | 239,742 | 237,837 | 214,129 | Upgrade |
Gross Profit | 25,205 | 24,521 | 22,747 | 23,896 | 26,171 | 35,197 | Upgrade |
Selling, General & Admin | 22,598 | 21,523 | 19,148 | 19,567 | 21,248 | 24,359 | Upgrade |
Operating Expenses | 22,598 | 21,523 | 19,148 | 19,567 | 21,248 | 24,359 | Upgrade |
Operating Income | 2,607 | 2,999 | 3,599 | 4,329 | 4,923 | 10,838 | Upgrade |
Interest Expense | -1,392 | -1,392 | -2,310 | -1,976 | -1,862 | -3,751 | Upgrade |
Interest & Investment Income | 2.65 | 2.65 | 4.93 | 5.61 | 131.8 | 9.35 | Upgrade |
Other Non Operating Income (Expenses) | 452.34 | 105.62 | 338.15 | -801.44 | 1,433 | 114.53 | Upgrade |
EBT Excluding Unusual Items | 1,670 | 1,715 | 1,633 | 1,557 | 4,626 | 7,212 | Upgrade |
Gain (Loss) on Sale of Investments | -205.92 | -205.92 | 56.16 | - | - | - | Upgrade |
Pretax Income | 1,464 | 1,509 | 1,689 | 1,557 | 4,626 | 7,212 | Upgrade |
Income Tax Expense | 439.02 | 412.43 | 561.43 | 466.97 | 869.74 | 1,890 | Upgrade |
Net Income | 1,025 | 1,097 | 1,128 | 1,090 | 3,756 | 5,322 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | 367.51 | - | - | - | Upgrade |
Net Income to Common | 1,025 | 1,097 | 760 | 1,090 | 3,756 | 5,322 | Upgrade |
Net Income Growth | -0.67% | -2.70% | 3.42% | -70.97% | -29.42% | -5.88% | Upgrade |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade |
Shares Change (YoY) | 0.07% | - | 0.04% | -0.08% | 0.01% | 0.03% | Upgrade |
EPS (Basic) | 269.66 | 288.70 | 200.00 | 287.00 | 988.00 | 1400.00 | Upgrade |
EPS (Diluted) | 269.66 | 288.70 | 200.00 | 287.00 | 988.00 | 1400.00 | Upgrade |
EPS Growth | 54.14% | 44.35% | -30.31% | -70.95% | -29.43% | -5.91% | Upgrade |
Free Cash Flow | -1,191 | 15,398 | 1,841 | -7,758 | 25,542 | 19,533 | Upgrade |
Free Cash Flow Per Share | -313.15 | 4052.20 | 484.34 | -2042.44 | 6718.80 | 5138.70 | Upgrade |
Dividend Per Share | - | - | 200.000 | 200.000 | 300.000 | - | Upgrade |
Dividend Growth | - | - | - | -33.33% | - | - | Upgrade |
Gross Margin | 9.36% | 9.12% | 9.99% | 9.06% | 9.91% | 14.12% | Upgrade |
Operating Margin | 0.97% | 1.11% | 1.58% | 1.64% | 1.86% | 4.35% | Upgrade |
Profit Margin | 0.38% | 0.41% | 0.33% | 0.41% | 1.42% | 2.13% | Upgrade |
Free Cash Flow Margin | -0.44% | 5.73% | 0.81% | -2.94% | 9.68% | 7.83% | Upgrade |
EBITDA | 3,309 | 3,720 | 4,495 | 5,456 | 6,048 | 12,101 | Upgrade |
EBITDA Margin | 1.23% | 1.38% | 1.98% | 2.07% | 2.29% | 4.85% | Upgrade |
D&A For EBITDA | 702.33 | 721.63 | 896.03 | 1,128 | 1,125 | 1,262 | Upgrade |
EBIT | 2,607 | 2,999 | 3,599 | 4,329 | 4,923 | 10,838 | Upgrade |
EBIT Margin | 0.97% | 1.11% | 1.58% | 1.64% | 1.86% | 4.35% | Upgrade |
Effective Tax Rate | 29.98% | 27.32% | 33.24% | 29.99% | 18.80% | 26.21% | Upgrade |
Revenue as Reported | 269,350 | 268,891 | 227,620 | 263,638 | 264,008 | 249,326 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.